Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05226104 · ClinicalTrials.gov registry record · NA
Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes.
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05226104 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT05226104, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single-site, non-randomized, non-controlled study at UT Southwestern Medical Center at Dallas in the Department of Plastic Surgery designed to follow up to 30 qualified and consenting subjects receiving a fractionated 1927 combination treatments for diffuse hyperpigmentation and/or melasma. Patients will receive treatment using f1927 devices and will be treated twice over the affected areas, once each month for a total of two months, followed by two follow-up visits at 1-month and 3-months post-treatment.
Interventions
- DEVICE MOXI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2022-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05226104
The ClinicalTrials.gov registry entry for NCT05226104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MOXI is the first listed.
NCT05226104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05226104 about?
NCT05226104 is a clinical study titled "Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes.". This is a single-site, non-randomized, non-controlled study at UT Southwestern Medical Center at Dallas in the Department of Plastic Surgery designed to follow up to 30 qualified and consenting subjects receiving a fractionated 1927 combination treatments for diffuse hyperpigmentation and/or melasma...
What is the current status of trial NCT05226104?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-18. Estimated completion is 2022-09-28.
What interventions are being tested in trial NCT05226104?
The interventions under investigation include: MOXI (DEVICE).
Who is sponsoring clinical trial NCT05226104?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.